![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 12587 | Ordered by Person (ascending)
1 2 3 ... 124 125 126 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Wotton, Paul (Sigilon Therapeutics –201804 CEO LEFT 4/18) | Chief Executive Officer (CEO) | Eli Lilly (Group) | United States (USA) |
| Wren, John (Omnicom 201307 CEO) | Chief Executive Officer (CEO) | Omnicom (Group) | United States (USA) |
| Wright, Dara (Bio-Rad 202208 EVP + President of Clinical Diagnostics Group) | President/Director/Head Business Group/Unit/Division | Bio-Rad (Group) | United States (USA) |
| Wright, David P. (PharmAthene 200601 CEO) | Chief Executive Officer (CEO) | PharmAthene Inc. | United States (USA) |
| Wright, Erica (Agilent 201801 HR VP of Global Talent) | Human Resources Manager | Agilent (Group) | United States (USA) |
| Wright, Fraser (Yposkesi 201807– Senior Advisor before co-founder + CTO of Spark Therapeutics + Avigen) | Consultant (economic/technology) | SK Group (Group) | France |
| Wright, Robin (MiNA Therapeutics 202101– CFO before Pharming + Karolinska Development + Orexo + Citibank) | Chief Financial Officer (CFO) | MiNA Therapeutics Ltd. | United Kingdom (GB) |
| Wright, Teresa (Roche Molecular 200809 CMO) | Chief Medical Officer (CMO) | Roche (Group) | United States (USA) |
| Wright, Timothy M. (TIME BioVentures 202012 General Partner before Regulus Therapeutic + CIBR + Novartis + Pfizer) | General Partner (venture partner) | TIME BioVentures | |
| Wrighton-Smith, Peter (Oxford Immunotec 200508 CEO) | Chief Executive Officer (CEO) | Oxford Immunotec (Group) | United Kingdom (GB) |
| Wrobel, Walter-G. (Retina Implant 201603 CEO) | Chief Executive Officer (CEO) | Retina Implant AG | Germany |
| Wu, Ching (Excellims 202107 CEO + Founder) | Chief Executive Officer (CEO) | Excellims Corporation | United States (USA) |
| Wu, Dee (University of Oklahoma Health Sciences Center 200610 Associate Prof) | n. a. | University of Oklahoma | United States (USA) |
| Wu, Eddy (VWR International 201108 SVP + President Asia Pacific) | President/Director/Head Business Group/Unit/Division | Avantor (Group) | United States (USA) |
| Wu, Jennifer (Digilab Genomic Solutions 200804 Global Product Manager Genomics + Liquid Handling Systems) | Product Manager (personnel) | Digilab (Group) | United States (USA) |
| Wu, Lena (Intabio 201709 CEO + Co-Founder) | Chief Executive Officer (CEO) | Danaher (Group) | United States (USA) |
| Wu, Xiaodong (China Medical Technologies 201108 CEO) | Chief Executive Officer (CEO) | China Medical Technologies (Group) | China |
| Wuite, Frans (Acesion Pharma 201604– CEO before Oncos Therapeutics + Amgen + Warren & Araim Pharma) | Chief Executive Officer (CEO) | Acesion Pharma ApS | Denmark |
| Wulf, John J. (Y's Therapeutics 200410– President of US sub + global CBO before InterMune before Axys + Genentech) | Chief Business Officer (CBO) | Y's Therapeutics (Group) | United States (USA) |
| Wulf, Sylke (Thermo Fisher 201006 Thermo Fisher Deutschland Regional Head Chromatography North) | Regional manager | Thermo Fisher (Group) | Germany |
| Wurm, Thomas (Single Use Support 201911 Managing Director + Co-Founder) | n. a. | Single Use Support GmbH (SUS) | Austria |
| Wurst, Helmut (Cellendes GmbH 200907– Managing Director + Founder) | Managing Director | Cellendes GmbH | Germany |
| Wyatt, Cliff (Wyatt Technology 201705 EVP) | President/Director/Head Business Group/Unit/Division | Waters (Group) | United States (USA) |
| Wyatt, Geof (Wyatt Technology 201007 President) | President/Director/Head Business Group/Unit/Division | Waters (Group) | United States (USA) |
| Wyatt, Philip (Wyatt Technology 202302 Founder + Chairman) | Company Founder | Waters (Group) | United States (USA) |
| Wylde, James (Astrotech 201201 VP Business Development at 1st Detect Corp) | Business Development Manager / Strategy Manager | Astrotech (Group) | United States (USA) |
| Wyle, Heidi (MIT/Whitehead 200501) | n. a. | MIT (Massachusetts Institute of Technology) | United States (USA) |
| Wüller, Conrad (ArtBio 202401 Director Strategy + Operations) | Business Development Manager / Strategy Manager | ||
| Wünsch, Josef R. (BASF 201109 Managing Director of BASF Venture Capital GmbH) | Managing Director | BASF (Group) | Germany |
| Wyrobek, Thomas (Hysitron 201701 CEO + Co-Founder) | Chief Executive Officer (CEO) | Bruker (Group) | United States (USA) |
| Wyser-Pratte, Joelle (OCP Capital LLC 202010 Founder) | Company Founder | OCP Capital LLC | United States (USA) |
| Wysocki, Vicki (Ohio State Univ 201509 Professor of Chemistry + Biochemistry + Head of Chemical Instrument Center) | Professor | Ohio State University | United States (USA) |
| Wyss, Hansjörg | n. a. | ||
| Wüst, Bernhard (Agilent 201909 Global Marketing Manager for Sports Doping) | Sales Manager / Marketing Manager | Agilent (Group) | United States (USA) |
| Wyszkowski, Leon (Thermo Fisher 201511 VP Clinical Services for North America + Facility Network) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | United States (USA) |
| Wyzga, Michael (VectorY 202303– CFO before Yumanity Therapeutics + vormerly Needham & Co + Citigroup) | Chief Financial Officer (CFO) | VectorY (Group) | Netherlands |
| Xanthopoulos, Kleanthis G. (Shoreline Biosciences 202111 CEO formerly Regulus Therapeutics 200811 CEO before Anadys) | Chief Executive Officer (CEO) | Shoreline Biosciences Inc. | United States (USA) |
| Xi, Hualin (Simon) (Rgenta Therapeutics 202004 CEO + CO-Founder) | Chief Executive Officer (CEO) | Rgenta Therapeutics Inc. | United States (USA) |
| Xia, Kang (Mississippi State Univ 201007 Assoc Prof State Chemical Lab) | Researcher (university / research institute) | Mississippi State University (MSU) | United States (USA) |
| Xiang, Vincent (Hillhouse Capital 201912 Managing Director) | Managing Director | Hillhouse Capital Management | |
| Xiao, Changchun (Sanofi 202211 Head of China Research) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | China |
| Xie, Kevin (Gracell Biotechnologies 202007– CFO before Fosun Healthcare Holdings + Locust Walk Capital + Scopia Capital) | Chief Financial Officer (CFO) | AstraZeneca (Group) | China |
| Xinqun, Lu (Bohui 201506 CEO) | Chief Executive Officer (CEO) | Bohui (Group) | China |
| Xu, Caroline Man (ViGeneron 201911 CEO + Co-Founder) | Chief Executive Officer (CEO) | ViGeneron GmbH | Germany |
| Xu, Hongliang (Leo) (Cerno Bioscience 201102 Software Development Manager) | Research & Development Manager | Cerno Bioscience LLC | United States (USA) |
| Xu, Joanne (SoftBank 202106 Partner at SoftBank Investment Advisers + 202106– Board Director at Exscientia) | Partner (venture partner) | SoftBank (Group) | |
| Xu, Jun Quan (CapitalBio 201603 CEO) | Chief Executive Officer (CEO) | CapitalBio (Group) | China |
| Xu, Yao-Chang (Abbisko Therapeutics 2023 CEO + Co-Founder) | Chief Executive Officer (CEO) | Abbisko Therapeutics Co. Ltd. | China |
| Xue, Tongtong (MediLink Therapeutics 202203 CEO + Founder) | Chief Executive Officer (CEO) | MediLink Therapeutics (Group) | China |
| Yakneen, Sergei (Alphabet 202205– CTO at Isomorphic Labs before Sophia Genetics + Amazon + BPS) | Chief Technology/Technical Officer (CTO) | Alphabet (formerly Google) (Group) | United Kingdom (GB) |
| Yakovlev, Nikolay (Bruker 201206 General Director of Bruker Ltd) | President/Director/Head Business Group/Unit/Division | Bruker (Group) | Russian Federation |
| Yamada, Tadataka (Tachi) (Frazier 201902 Venture Partner at Frazier Healthcare before Takeda + Gates Foundation + GSK) | Partner (venture partner) | Frazier (Group) | United States (USA) |
| Yamaguchi, Yutaka (Fujifilm 201901 CEO of Fujifilm Irvine Scientific Inc) | Chief Executive Officer (CEO) | Fujifilm (Group) | United States (USA) |
| Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) | Professor | University of Kyoto (Kyoto University) | Japan |
| Yamanaka, Yvonne (VenBio 201910 VP) | Investment Manager | VenBio (Group) | United States (USA) |
| Yamane, Kenji (KKR 201506 President of Panasonic Healthcare + Panasonic Healthcare Holdings) | President/Director/Head Business Group/Unit/Division | PHC (Group) | Japan |
| Yanai, Shlomo (Teva 200706 President + CEO) | Chief Executive Officer (CEO) | Teva (Group) | Israel |
| Yanchik, Joseph A., III (Aileron Therapeutics 201008 CEO) | Chief Executive Officer (CEO) | Aileron Therapeutics Inc. | United States (USA) |
| Yancopoulos, George D. (Regeneron 200703 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Regeneron (Group) | United States (USA) |
| Yanek, Melanie (Thermo Fisher Scientific UK 200710 Product Manager ABgene) | Product Manager (personnel) | Thermo Fisher (Group) | United States (USA) |
| Yanes, Oscar (Rovira i Virgili University 201209– Principal Investigator at Centre for Omic Sciences) | Researcher (university / research institute) | Rovira i Virgili University of Tarragona (Universitat Rovira i Virgili, URV) | Spain (España) |
| Yang, Chengyong (Ascendas Genomics 2010707 CEO) | Chief Executive Officer (CEO) | Ascendas Genomics (Group) | China |
| Yang, Luhan (eGenesis 201603– CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | eGenesis (Group) | United States (USA) |
| Yang, Lynn (Sequoia Capital 201805 Managing Director of Sequoia China) | Managing Director | Sequoia Capital (Group) | China |
| Yang, Max (Agilent China 200704 VP + General Manager) | General Manager (management) | Agilent (Group) | United States (USA) |
| Yang, Patrick (National Resilience 202106 Exec Vice Chairman + Board Member at Antheia formerly Roche/Genentech) | Board member, executive | National Resilience (Group) | United States (USA) |
| Yang, Q. David (MicroConstants 201011 CEO of MicroConstants China Inc) | Chief Executive Officer (CEO) | MicroConstants (Group) | China |
| Yang, Steve (WuXi PharmaTech 201604 EVP + COO of WuXi AppTec) | Chief Operating Officer (COO) | WuXi PharmaTech (Group) | China |
| Yano, Jim (Agilent 201506 Marketing Manager Mass Spectrometry) | Sales Manager / Marketing Manager | Agilent (Group) | United States (USA) |
| Yao, Lina (Teon Therapeutics 202102 CEO + Founder) | Chief Executive Officer (CEO) | Teon Therapeutics (US) | United States (USA) |
| Yao, Stephanie (Bicycle Therapeutics 202310 SVP Investor Relations + Communciations formerly Kronos Bio) | Public Relations Manager / Investor Relations Manager | Kronos Bio Inc. (Nasdaq: KRON) | United States (USA) |
| Yao, Tony (ArrowMark Partners 201806) | Investment Manager | ArrowMark Partners | |
| Yao, Zhengbin (Bing) (ArriVent BioPharma 202401 CEO + Co-Founder before Viela Bio + MedImmune) | Chief Executive Officer (CEO) | Viela Bio Inc. | United States (USA) |
| Yap, Greg (Menlo Ventures 202101 Partner formerly Desy + GE + Ventana + Cellective Dx + Affymetrix) | Partner (venture partner) | Menlo Ventures | United States (USA) |
| Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) | Managing Director | Numares (Group) | Singapore |
| Yared, Nadim (CVRx 202007 CEO) | Chief Executive Officer (CEO) | CVRx Inc. | United States (USA) |
| Yarkoni, Shai (Cellect Biotechnology 202012 CEO) | Chief Executive Officer (CEO) | Cellect Biotechnology Ltd. | Israel |
| Yarnell, Kellie (Expression Analysis 200702 US Sales Representative Eastern region) | Sales Manager / Marketing Manager | Iqvia (Group) | United States (USA) |
| Yasiejko, Michael (Tempus Labs 202302 EVP) | n. a. | Tempus Labs Inc. | United States (USA) |
| Yasukawa, Kenji (Astellas 201808 CEO) | Chief Executive Officer (CEO) | Astellas (Group) | Japan |
| Yates, Barbara (Yates Network 2000– Founder before VP Corp Comms for Serono Inc) | Public Relations Manager / Investor Relations Manager | Yates Network, The | United States (USA) |
| Yates, John R, III (Scripps Research) | Professor | Scripps Research Institute, The (TSRI) | United States (USA) |
| Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | United States (USA) |
| Ybert, Thomas (DNA Script 201709 CEO + Co-Founder) | Chief Executive Officer (CEO) | DNA Script (Group) | France |
| Yeadon, Mike (Ziarco Pharma 201211– CEO + founder before Pfizer Research UK) | Chief Executive Officer (CEO) | Novartis (Group) | United Kingdom (GB) |
| Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) | Board member, executive | Eckert & Ziegler (Group) | Germany |
| Yeatman, Eric (Microsaic Systems 201307– Non-exeuctive Director before Chairman + acting CEO) | Board member, non-executive | Microsaic Systems plc (AIM: MSYS) | United Kingdom (GB) |
| Yedid, Bob (LifeSci 201806 LifeSci Advisors LLC) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | United States (USA) |
| Yee, James P. (XDx 200608– CMO before Celera Genomics) | Chief Medical Officer (CMO) | CareDx (Group) | United States (USA) |
| Yelle, Erik (Warnex 200601– VP Sales + Marketing before McCain Foods) | n. a. | Warnex (Group) | Canada |
| Yelle, Michael (Mike) (Waters 201405 VP Consumable Business Unit) | President/Director/Head Business Group/Unit/Division | Waters (Group) | United States (USA) |
| Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) | Chief Commercial Officer (CCO) | Optibrium (Group) | United Kingdom (GB) |
| Yeo, Bryan (Singapore (govt) 201803 Chief Investment Officer of Public Equities at GIC) | Investment Manager | Singapore (govt) | Singapore |
| Yeo, Marcus (Definigen Ltd 201406 CEO) | Chief Executive Officer (CEO) | DefiniGen Ltd. | United Kingdom (GB) |
| Yeok, Chu Swee (EDBI (SG) 202003 CEO) | Chief Executive Officer (CEO) | EDBI (SG) | Singapore |
| Yeshwant, Krishna (Alphabet 201703 General Partner at GV) | General Partner (venture partner) | Alphabet (formerly Google) (Group) | United States (USA) |
| Yeung, Edward (Iowa State Univ 201603) | n. a. | Iowa State University | United States (USA) |
| Yeung, Gary (Erasa 201812 CBO) | Chief Business Officer (CBO) | Erasca Inc. | United States (USA) |
| Yi, Kathy (Cerevel 201909 CFO) | Chief Financial Officer (CFO) | AbbVie (Group) | United States (USA) |
| Yi, Yong (Agilent 201302 Associate Director of Marketing for Genomics) | Sales Manager / Marketing Manager | Agilent (Group) | United States (USA) |
1 2 3 ... 124 125 126
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
